The first and largest genetic association study in the Middle East revealed genetic variations that are specific to the Qatari population, a group of researchers at Qatar Foundation reported Feb. 23 in Nature Communications.
With highly qualified doctors needed now more than ever, Weill Cornell Medicine-Qatar welcomed its new cohort of incoming students with a comprehensive three-day orientation program – delivered fully online this year for the first time in the institution’s history.
Medical students at Weill Cornell Medicine-Qatar (WCM-Q) have answered a call from the Ministry of Public Health (MOPH) for volunteers to help tackle the COVID-19 pandemic.
As the epicenter of the COVID-19 pandemic moves to Latin America and Africa, Weill Cornell Medicine faculty based in Haiti, a country hard hit by natural disasters and poverty, have developed lessons on what low-resourced countries can do to address and treat the outbreak on the ground.
An intensive, one-year, lifestyle-modification treatment for type 2 diabetes patients, featuring a low-calorie diet and physical exercise, resulted in a large average weight loss, and remission of diabetes for most patients, in a clinical trial led by researchers at Weill Cornell Medicine-Qatar.
A drug that blocks a male hormone receptor prolonged life by nearly a year compared with the placebo in men with nonmetastatic, castration-resistant prostate cancer, according to the final analysis of the results of an international, multi-center Phase 3 clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators.
Weill Cornell Medicine–Qatar on May 6 celebrated the dedication and hard work of some of the world’s newest doctors as the Class of 2020 received their Cornell University medical degrees during commencement.
Weill Cornell Medicine, in collaboration with the Moffitt Cancer Center in Tampa, Florida and the Universidade de São Paulo in Brazil, has been awarded a five-year, $8.3 million grant from the National Cancer Institute to investigate ways to prevent human papillomavirus (HPV)-related cancers in people living with human immunodeficiency virus (HIV) infection.
Weill Cornell Medicine and GHESKIO have received a two-year $158,000 grant from LINKS to support the institutions’ work addressing high blood pressure in Haiti’s most vulnerable communities.
Dr. Kathryn Dupnik, an assistant professor of medicine at Weill Cornell Medicine, has been awarded a 2019 Clinical Scientist Development Awardby the Doris Duke Charitable Foundation.
Dr. Robert Peck, an assistant professor of medicine and of pediatrics at Weill Cornell Medicine, has been awarded the 2019 Dr. Nathan Davis International Award in Medicine by the American Medical Association Foundation.
The work of global oncologists – whose insights and innovations reduce the burden of cancer around the world – has demonstrated value that academic medical leadership should consider when assessing these physicians for professional advancement, according to a commentary by Weill Cornell Medicine investigators.
A set of gene variants that originated in Sub-Saharan West African populations may help explain why black women, compared to white women, have worse breast cancer outcomes, according to a new study from a team led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.
An existing malaria drug could improve the effectiveness of a new class of cancer therapies, called glutaminase inhibitors, if used in combination, researchers at Weill Cornell Medicine-Qatar (WCM-Q) discovered in a new study.
Weill Cornell Medicine-Qatar welcomed 34 new doctors, including 13 Qatari nationals—a landmark for the institution—into the medical profession during commencement on May 2.
